Filter
234
Text search:
drug-related
problems
Featured
Recommendations
17
New Publications
51
Language
Document type
No document type
185
Guidelines
18
Studies & Reports
14
Manuals
8
Training Material
2
Resource Platforms
2
Strategic & Response Plan
2
Fact sheets
2
Situation Updates
1
Countries / Regions
Western and Central Europe
15
Nigeria
7
India
7
Nepal
7
Uganda
6
Zambia
6
Eastern Europe
5
Sierra Leone
4
Ethiopia
4
Ghana
4
Kenya
3
Rwanda
3
Bangladesh
3
Namibia
3
Ukraine
3
Myanmar / Burma
3
South–East Asia Region
3
Tajikistan
3
Global
3
Liberia
2
Tanzania
2
Thailand
2
Chile
2
East and Southern Africa
2
Asia
2
Poland
2
Albania
2
Cameroon
1
Zimbabwe
1
Philippines
1
Germany
1
Cambodia
1
Indonesia
1
South Africa
1
Argentina
1
North Macedonia
1
Serbia
1
Hungary
1
Botswana
1
Lesotho
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Armenia
1
Canada
1
Estonia
1
Moldova
1
Uzbekistan
1
Authors & Publishers
Publication Years
Category
Countries
70
Capacity Building
10
Clinical Guidelines
10
Public Health
6
Pharmacy & Technologies
2
Key Resources
1
Toolboxes
Mental Health
76
HIV
41
TB
19
Pharmacy
12
COVID-19
2
Social Ethics
2
Caregiver
2
NTDs
2
Ebola
1
Refugee
1
Global Health Education
1
The booklet starts with a general overview of how illicit drugs and the environment are linked within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability. It highlights direct and indirect linkages and gives examples of the significant local and i
...
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understanding of the vulnerabilities to HIV acquisition among P
...
Accessed: 28.03.2019
EMCDDA Insights - 11
Accessed: 14.03.2019
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview
...
Guidance Brief
Selected findings from ECDC and EMCDDA scientific guidance, 2018
World Psychiatry16:2 - June 2017
First published: 12 May 2017
https://doi.org/10.1002/wps.20428
Volume16, Issue2; Pages 213-214
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
2nd revised edition. Accessed Apri. 17, 2019
Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar
...
Technical Report
An update from the EU Early Warning System
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac
...
Technical Brief
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
